Johnson & Johnson May Not Have to Wait Long for Its Next Blockbuster Vaccine

Johnson & Johnson May Not Have to Wait Long for Its Next Blockbuster Vaccine

Source: 
Motley Fool
snippet: 
  • The company announced the vaccine's advancement to phase 3 clinical trials.
  • It could be on the market by the end of 2023 and on its way to blockbuster status.
  • Its stock is a buy for income investors looking for a safe and growing dividend.